NEXGEL (NXGL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 revenue doubled year-over-year to $2.88 million, driven by growth in both contract manufacturing and branded consumer products, including contributions from recent acquisitions.
Gross margin improved to 43.6% from 20.3% in Q2 2024, reflecting higher sales of consumer branded products and operational leverage.
Net loss attributable to stockholders narrowed to $670,000 from $890,000 year-over-year, with sequential improvement from Q1 2025.
Cash balance as of June 30, 2025, was $0.73 million, with additional $1 million from STADA and $1.05 million from a direct offering post-quarter.
Management is focused on expanding branded consumer products, contract manufacturing, and strategic partnerships, while exploring new product channels.
Financial highlights
Q2 2025 revenue: $2.88 million, up 100.3% year-over-year; gross profit: $1.26 million (43.6% margin).
EBITDA loss narrowed to $530,000 from $760,000, and adjusted EBITDA loss to $420,000 from $790,000 year-over-year.
Operating expenses for Q2 2025 increased to $1.89 million, mainly due to higher compensation, advertising, and professional fees.
Cash used in operations for the first half of 2025 was $0.81 million, down from $1.79 million in the prior year.
Working capital at June 30, 2025, was $1.77 million.
Outlook and guidance
Management reaffirmed 2025 guidance of $13 million in revenue and expects to achieve positive EBITDA during the year.
Anticipates a seasonally strong second half, with new product launches and expanded partnerships expected to drive growth.
Additional capital raises through debt or equity may be necessary to support growth and acquisitions.
Latest events from NEXGEL
- Hydrogel innovation and strategic partnerships fuel rapid growth and expanding product lines.NXGL
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Record Q2 revenue and strong outlook driven by branded products and Silly George growth.NXGL
Q2 20242 Feb 2026 - Q3 revenue up 141% to $2.94M, gross margin 43.6%, but losses and risks persist.NXGL
Q3 202414 Jan 2026 - Strong growth from product innovation, acquisitions, and major partnerships, with profitability in focus.NXGL
IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 202411 Jan 2026 - Record revenue growth and improved margins set stage for positive EBITDA in 2025.NXGL
Q4 202424 Dec 2025 - Shareholders will vote on director elections, incentive plan expansion, and executive pay, all backed by the Board.NXGL
Proxy Filing2 Dec 2025 - Vote to increase authorized common stock to 1B shares for future flexibility is recommended.NXGL
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 121%, margin at 42.4%, and positive EBITDA targeted for 2025.NXGL
Q1 202527 Nov 2025 - Q3 revenue steady at $2.93M, gross margin up, nine-month revenue up 52.7%, risks persist.NXGL
Q3 202517 Nov 2025